| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/28/2001 | WO2001045638A2 Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death |
| 06/28/2001 | WO2001045510A1 Adeno-associated vectors for expression of factor viii by target cells |
| 06/28/2001 | WO2001045495A2 Potassium channel stress-related proteins and methods of use in plants |
| 06/28/2001 | WO2001045494A2 Pyrophosphatase stress-related proteins and methods of use in plants |
| 06/28/2001 | WO2001045493A2 Transcription factor stress-related proteins and methods of use in plants |
| 06/28/2001 | WO2001045492A2 Protein kinase stress-related proteins and methods of use in plants |
| 06/28/2001 | WO2001040464A8 Interleukin-1-receptor associated kinase-3 (irak3) and its use in promotion or inhibition of angiogenesis and cardiovascularization |
| 06/28/2001 | WO2001038351A9 Nucleotide sequence of the shrimp white spot syndrome bacilliformvirus (wsbv), systems containing this sequence and detection kits |
| 06/28/2001 | WO2001005974A9 The il-1l1 gene and polypeptide products |
| 06/28/2001 | WO2001004148A3 Donor strand complemented pilin and adhesin broad-based vaccines |
| 06/28/2001 | WO2001002561A3 Mammalian calcium channels and related probes, cell lines and methods |
| 06/28/2001 | WO2000078927A3 Spheroid preparation |
| 06/28/2001 | WO2000077042A3 Parathyroid hormone receptor ligands |
| 06/28/2001 | WO2000077036A3 Gene pls1 (or gene 421) of the causal fungus of magnaporthe grisea rice indispensable for the fungus pathogenesis |
| 06/28/2001 | WO2000075359A3 Gene encoding short integuments and uses thereof |
| 06/28/2001 | WO2000075324A3 Recombinant prion-like genes and proteins and materials and methods comprising same |
| 06/28/2001 | WO2000075305A3 Candida albicans genes and proteins coded by said genes |
| 06/28/2001 | WO2000075280A3 A member of the frzb family, frazzled |
| 06/28/2001 | WO2000073462A3 Attenuated mutant enteropathogenic e. coli (epec) strains, process for their production and their use |
| 06/28/2001 | WO2000073452A3 Compositions and methods for the treatment of immune related diseases |
| 06/28/2001 | WO2000073446A3 Adipocyte complement related protein homolog zacrp6 |
| 06/28/2001 | WO2000073333A3 Ligand for cd7, and methods for use thereof |
| 06/28/2001 | WO2000071741A3 Dna encoding a human subunit of the 5-ht3 serotonin receptor |
| 06/28/2001 | WO2000071725A3 Combination neisserial compositions |
| 06/28/2001 | WO2000071565A3 Fluorescent protein indicators |
| 06/28/2001 | WO2000071149A3 Therapeutic uses of bpi protein products in humans with otitis media with effusion |
| 06/28/2001 | WO2000070351A3 Protein-protein interactions and methods for identifying them |
| 06/28/2001 | WO2000070049A3 Extracellular signaling molecules |
| 06/28/2001 | WO2000070047A3 Full-length molecules expressed in human tissues |
| 06/28/2001 | WO2000068247A3 Serine proteases |
| 06/28/2001 | WO2000066731A3 Recombinant laminin 5 |
| 06/28/2001 | WO2000066708A9 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 06/28/2001 | WO2000063236A3 Adhesion modulatory peptides and methods for use |
| 06/28/2001 | WO2000061753A3 Compositions and methods for the treatment and diagnosis of breast cancer |
| 06/28/2001 | WO2000060359A3 Interactions of ku polypeptides |
| 06/28/2001 | WO2000060079A3 New members of tnf and tnfr families |
| 06/28/2001 | WO2000055321A3 Vertebrate protein slit, dna sequence encoding it and uses thereof |
| 06/28/2001 | WO2000055194A3 Tuberculosis antigens and methods of use therefor |
| 06/28/2001 | WO2000004040A9 Constitutive disease resistance gene (cdr1), and methods of use thereof |
| 06/28/2001 | WO1999064461A9 Monoclonal antibodies, cross-reactive antibodies and method for producing the same |
| 06/28/2001 | WO1999046575A3 Peptides containing a cholesterol recognition sequence and their uses |
| 06/28/2001 | WO1997046686A3 Tumor necrosis factor-related polypeptide |
| 06/28/2001 | WO1997039029A3 An antigenic epitope of the a determinant of hepatitis b surface antigen and uses thereof |
| 06/28/2001 | US20010005750 Fed-batch cultivation of a microorganism in a bioreactor containing a medium comprising carbon, nitrogen and mineral salt sources, cultivation is carried out by addition of organic carbon source by oscillation feed |
| 06/28/2001 | US20010005747 Bispecific molecules comprising a target cell specific ligand and an effector cell specific antibody or functional antibody fragment |
| 06/28/2001 | US20010005746 Stomatin-like genes and their use in plants |
| 06/28/2001 | US20010005714 Amphipathic molecules as cholesterol and other lipid uptake inhibitors |
| 06/28/2001 | US20010005713 Use of heat shock proteins to deliver moieties into cells |
| 06/28/2001 | US20010005578 Contacting a sample in a flowable liquid state with a solid substrate comprised of a prion complexing agent and allowing the sample to remain in contact with substrate for time such that prions in the sample bind to the substrate |
| 06/28/2001 | US20010005507 Predictive test for hepatitis-B resistance |
| 06/28/2001 | DE19962583A1 New antibodies specific for plasma cells, useful for treatment and diagnosis of autoimmune diseases and plasma cell tumors |
| 06/28/2001 | DE19960843A1 Wurzelspezifischer Promotor Root-specific promoter |
| 06/28/2001 | DE19959045A1 Adeno-associated virus vectors that express monocyte chemotactic protein-1, useful for gene therapy of cancers, promotion of angiogenesis and treatment of inflammation |
| 06/28/2001 | DE19958961A1 New plant nucleic acid transcribed quickly after pathogen infection, useful e.g. for increasing pathogen resistance of crops, especially potatoes against Phytophthora infestans |
| 06/28/2001 | DE19957065A1 Screening-Verfahren für Arzneistoffe A screening method for drugs |
| 06/28/2001 | DE10027954A1 Humanes Procalcitonin, dessen Herstellung und Verwendung Human procalcitonin, its preparation and use |
| 06/28/2001 | CA2398207A1 Methods for protecting against lethal infection with bacillus anthracis |
| 06/28/2001 | CA2395714A1 Novel tachykinin-like polypeptides and use thereof |
| 06/28/2001 | CA2395525A1 Transferrin polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | CA2395429A1 Polynucleotide vaccines expressing codon optimized hiv-1 pol and modified hiv-1 pol |
| 06/28/2001 | CA2395416A1 P2y12 receptor |
| 06/28/2001 | CA2395406A1 Method for treating inflammation |
| 06/28/2001 | CA2395369A1 Cytokine zcyto18 |
| 06/28/2001 | CA2395269A1 Molecular clones with mutated hiv gag/pol, siv gag and siv env genes |
| 06/28/2001 | CA2395247A1 Novel human membrane proteins and polynucleotides encoding the same |
| 06/28/2001 | CA2395212A1 Polynucleotides and polypeptides encoded thereby |
| 06/28/2001 | CA2395208A1 Nucleic acid vaccination |
| 06/28/2001 | CA2395007A1 Transporters and ion channels |
| 06/28/2001 | CA2394877A1 Compounds and use thereof to modify transport across cell membranes |
| 06/28/2001 | CA2394757A1 Novel gene and use thereof |
| 06/28/2001 | CA2394743A1 Inhibition of .beta.arrestin mediated effects prolongs and potentiates opioid receptor-mediated analgesia |
| 06/28/2001 | CA2394741A1 Inducing cellular immune responses to prostate cancer antigens using peptide and nucleic acid compositions |
| 06/28/2001 | CA2394589A1 Modulation of pax-2 for controlled apoptosis or survival of cells |
| 06/28/2001 | CA2394049A1 Vesicle trafficking proteins |
| 06/28/2001 | CA2394015A1 Tweak receptor |
| 06/28/2001 | CA2393646A1 Survivin promotion of angiogenesis |
| 06/28/2001 | CA2393586A1 Use of heat shock proteins |
| 06/28/2001 | CA2393500A1 Methods and compositions for detecting hepatitis e virus |
| 06/28/2001 | CA2392787A1 Nk cell receptor polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | CA2392712A1 Multifunctional recombinant phycobiliprotein-based fluorescent constructs and phycobilisome display |
| 06/28/2001 | CA2391594A1 Trefoil domain-containing polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | CA2391374A1 Il-17 homologous polypeptides and therapeutic uses thereof |
| 06/28/2001 | CA2390691A1 Methods and compositions for prolonging elimination half-times of bioactive compounds |
| 06/27/2001 | EP1111388A1 Interaction between CD14 and HBV components |
| 06/27/2001 | EP1111068A1 Branched compound for use in nucleic acid detection and analysis reactions |
| 06/27/2001 | EP1111066A1 Recombinant human sm-11044-binding receptor protein having activity of binding to ligand and utilization thereof |
| 06/27/2001 | EP1111062A1 Nucleotide sequences encoding the gene zwa1 |
| 06/27/2001 | EP1111053A2 Peptide fragment of the respiratory syncytial virus G protein, immunogenic agent, pharmaceutical composition containing same, and preparation method |
| 06/27/2001 | EP1111052A1 Novel gene |
| 06/27/2001 | EP1111050A2 Human procalcitonin, its production and use |
| 06/27/2001 | EP1111049A1 Novel receptor protein and method for diagnosing inflammatory diseases by using the same |
| 06/27/2001 | EP1111048A2 Neutral amino acid transporter and gene thereof |
| 06/27/2001 | EP1111046A1 Novel protein and process for producing the same |
| 06/27/2001 | EP1111045A2 Apoptin-associating protein |
| 06/27/2001 | EP1111043A1 New QTL's on chromosomes X, 2, 6 and 7 of pigs |
| 06/27/2001 | EP1111041A1 Systemic carnitine deficiency gene and utilization thereof |
| 06/27/2001 | EP1110970A1 Anti-Procalcitonin antibody, their production and use |
| 06/27/2001 | EP1110969A1 Interleukin 18-binding protein |
| 06/27/2001 | EP1110967A1 Compound comprising a biomolecule moiety and an organo-silane moiety |
| 06/27/2001 | EP1109931A1 METHOD FOR STUDYING PROTEIN INTERACTIONS $i(IN VIVO) |